Literature DB >> 25288747

KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes.

Dong-In Koh1, Dohyun Han2, Hoon Ryu3, Won-Il Choi1, Bu-Nam Jeon1, Min-Kyeong Kim1, Youngsoo Kim2, Jin Young Kim4, Lee Parry5, Alan R Clarke5, Albert B Reynolds6, Man-Wook Hur7.   

Abstract

An unresolved issue in genotoxic stress response is identification of induced regulatory proteins and how these activate tumor suppressor p53 to determine appropriate cell responses. Transcription factor KAISO was previously described to repress transcription following binding to methylated DNA. In this study, we show that KAISO is induced by DNA damage in p53-expressing cells and then interacts with the p53-p300 complex to increase acetylation of p53 K320 and K382 residues, although decreasing K381 acetylation. Moreover, the p53 with this particular acetylation pattern shows increased DNA binding and potently induces cell cycle arrest and apoptosis by activating transcription of CDKN1A (cyclin-dependent kinase inhibitor 1) and various apoptotic genes. Analogously, in Kaiso KO mouse embryonic fibroblast cells, p53-to-promoter binding and up-regulation of p21 and apoptosis gene expression is significantly compromised. KAISO may therefore be a critical regulator of p53-mediated cell cycle arrest and apoptosis in response to various genotoxic stresses in mammalian cells.

Entities:  

Keywords:  KAISO; apoptosis; cell cycle arrest; p300; p53

Mesh:

Substances:

Year:  2014        PMID: 25288747      PMCID: PMC4210320          DOI: 10.1073/pnas.1318780111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  p53 post-translational modification: deregulated in tumorigenesis.

Authors:  Chao Dai; Wei Gu
Journal:  Trends Mol Med       Date:  2010-11       Impact factor: 11.951

Review 2.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 3.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 4.  Control of apoptosis by p53.

Authors:  Jordan S Fridman; Scott W Lowe
Journal:  Oncogene       Date:  2003-12-08       Impact factor: 9.867

5.  The transcriptional repressor Kaiso localizes at the mitotic spindle and is a constituent of the pericentriolar material.

Authors:  Adelheid Soubry; Katrien Staes; Eef Parthoens; Sam Noppen; Christophe Stove; Pieter Bogaert; Jolanda van Hengel; Frans van Roy
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

Review 6.  Modes of p53 regulation.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

Review 7.  PUMA, a potent killer with or without p53.

Authors:  J Yu; L Zhang
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

8.  Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate.

Authors:  Chad D Knights; Jason Catania; Simone Di Giovanni; Selen Muratoglu; Ricardo Perez; Amber Swartzbeck; Andrew A Quong; Xiaojing Zhang; Terry Beerman; Richard G Pestell; Maria Laura Avantaggiati
Journal:  J Cell Biol       Date:  2006-05-22       Impact factor: 10.539

9.  HIPK2 modulates p53 activity towards pro-apoptotic transcription.

Authors:  Rosa Puca; Lavinia Nardinocchi; Ada Sacchi; Gideon Rechavi; David Givol; Gabriella D'Orazi
Journal:  Mol Cancer       Date:  2009-10-14       Impact factor: 27.401

10.  A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed.

Authors:  Jesper V Olsen; Jae C Schwartz; Jens Griep-Raming; Michael L Nielsen; Eugen Damoc; Eduard Denisov; Oliver Lange; Philip Remes; Dennis Taylor; Maurizio Splendore; Eloy R Wouters; Michael Senko; Alexander Makarov; Matthias Mann; Stevan Horning
Journal:  Mol Cell Proteomics       Date:  2009-10-14       Impact factor: 5.911

View more
  23 in total

1.  Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression.

Authors:  Min-Kyeong Kim; Ji-Yang Song; Dong-In Koh; Jin Young Kim; Masahiko Hatano; Bu-Nam Jeon; Min-Young Kim; Su-Yeon Cho; Kyung-Sup Kim; Man-Wook Hur
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

2.  Temporal and differential regulation of KAISO-controlled transcription by phosphorylated and acetylated p53 highlights a crucial regulatory role of apoptosis.

Authors:  Seo-Hyun Choi; Dong-In Koh; Su-Yeon Cho; Min-Kyeong Kim; Kyung-Sup Kim; Man-Wook Hur
Journal:  J Biol Chem       Date:  2019-07-11       Impact factor: 5.157

3.  DeSUMOylation switches Kaiso from activator to repressor upon hyperosmotic stress.

Authors:  Svetlana Zhenilo; Igor Deyev; Ekaterina Litvinova; Nadezhda Zhigalova; Daria Kaplun; Alexey Sokolov; Alexander Mazur; Egor Prokhortchouk
Journal:  Cell Death Differ       Date:  2018-02-22       Impact factor: 15.828

4.  Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.

Authors:  Xiaoxiao Huang; Richard D LeDuc; Luca Fornelli; Alissa J Schunter; Richard L Bennett; Neil L Kelleher; Jonathan D Licht
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

5.  Deletion of murine Rhoh leads to de-repression of Bcl-6 via decreased KAISO levels and accelerates a malignancy phenotype in a murine model of lymphoma.

Authors:  Hiroto Horiguchi; Haiming Xu; Beatrice Duvert; Felicia Ciuculescu; Qiuming Yao; Amit Sinha; Meaghan McGuinness; Chad Harris; Christian Brendel; Anja Troeger; Roberto Chiarle; David A Williams
Journal:  Small GTPases       Date:  2022-01

6.  Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1.

Authors:  Amir Pozner; Tommy W Terooatea; Bethany A Buck-Koehntop
Journal:  J Biol Chem       Date:  2016-09-30       Impact factor: 5.157

7.  Expression and prognostic significance of cyclin-dependent kinase inhibitor 1A in patients with resected gastric adenocarcinoma.

Authors:  Youdong Lin; Xiaoting Wang; Yinghao Yu; Wei Liu; Feilai Xie; Xuenong Ouyang; Qiaojia Huang
Journal:  Oncol Lett       Date:  2017-09-29       Impact factor: 2.967

Review 8.  Beyond β-catenin: prospects for a larger catenin network in the nucleus.

Authors:  Pierre D McCrea; Cara J Gottardi
Journal:  Nat Rev Mol Cell Biol       Date:  2015-11-18       Impact factor: 94.444

9.  SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Junghee Lee; Yunha Kim; Tian Liu; Yu Jin Hwang; Seung Jae Hyeon; Hyeonjoo Im; Kyungeun Lee; Victor E Alvarez; Ann C McKee; Soo-Jong Um; Manwook Hur; Inhee Mook-Jung; Neil W Kowall; Hoon Ryu
Journal:  Aging Cell       Date:  2017-11-11       Impact factor: 9.304

10.  Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.

Authors:  Twishasri DasGupta; Emeka I Nweze; Hong Yue; Liming Wang; Jessica Jin; Santosh K Ghosh; Hameem I Kawsar; Chad Zender; Elliot J Androphy; Aaron Weinberg; Thomas S McCormick; Ge Jin
Journal:  Oncotarget       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.